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INTRODUCTION
The increase in the prevalence of allergic disorders over the past few decades is challenging the scientific community and medicare professionals. Allergy is a result of IgE-dependent and -independent hypersensitivity reactions (1) . Approximately 1 in 5 or 18.4% of people in the United States suffer from allergic diseases, and the prevalence is increasing daily, because to date, no curable therapy is available on the market for the treatment of allergic consequences. Hence, this demands the development of new prevention strategies to inhibit the rapidly increasing prevalence of allergic diseases. Use of probiotics as an alternative medicine for the treatment of allergy has emerged recently and has attracted the attention of many scientists worldwide (2) . Probiotics can be defined as 'live microorganisms that upon ingestion give several health benefits and considered as a generally recognized as safe (GRAS)' (3) . Various strains of lactic acid bacteria (LAB) especially lactobacilli and bifidobacteria are considered as probiotics and have been reported to suppress the allergic reactions in different animal models (4) (5) (6) as well as in human subjects (7) . Matsuzaki et al. (5) reported that feeding of the heat-killed Lactobacillus casei strain Shirota suppressed total IgE production in ovalbumin (OVA)-sensitized mice. Pohjavuori et al. (8) also showed that oral administration of L. rhamnosus GG elevated interferon (IFN)-γ production by peripheral blood mononuclear cells of infants with cow's milk allergy and IgE-associated dermatitis. It has been noticed that the anti-allergic effects of various strains of lactobacilli are strictly strain-dependent (9); thus, searching new, safer and more easily available probiotic LAB strains is an important area of present research in food science and nutrition.
Although various LAB have been reported for anti-allergic effects, few of them are available on the market in the form of tablets or powder. However, these commercially available products have various issues such as survivability, loss of efficiency to establish into the gut and psychological illness of patients. Thus, the addition of probiotic LAB with food, i.e. milk products, may overcome these limitations and provide nutritional benefits along with health benefits. It has been known that LAB can easily grow in dairy products, i.e. yogurt or Dahi, as they have a good buffering environment and essential nutrients for their growth. Considering all these facts, we developed a Dahi (yogurt) by incorporating two newly established probiotic strains (L. acidophilus and L. casei) along with Dahi cultures (named probiotic Dahi), with various technological modifications (10) . Preliminary studies have shown that ingestion of probiotic Dahi enhanced innate immune function in terms of increased production of sIgA and improved phagocytic activity of macrophages in mice (11) . On the basis of these results, we hypothesized that ingestion of probiotic Dahi may also strengthen the immune response against OVA-induced allergic consequences. Hence, in the present study, we made an attempt to examine the anti-allergic effects of probiotic Dahi on OVA-induced allergic mice.
MATERIALS AND METHODS

Bacterial Strains and Preparation of Dahi(s)
Probiotic strains L. acidophilus NCDC14, L. casei NCDC19 and Dahi starter culture Lactococcus lactis biovar diacetylactis NCDC-60 (DRC-1) were procured from the National Collection of Dairy Cultures (NCDC), National Dairy Research Institute, Karnal, India. Probiotic Dahi was prepared as described elsewhere (10) . In brief, standardized milk was inoculated with L. acidophilus (~10 7 CFU/ ml), L. casei (~10 4 CFU/ ml) along with DRC-1 (~10 6 CFU/ml) for preparation of probiotic Dahi and incubated at 37°C for 12-14 h. DRC-1 control Dahi was prepared by inoculating DRC-1 culture (~10 7 CFU/ ml) and then incubating at 30°C for 12-14 h.
Animals and Feeding Schedule
Swiss albino mice (6-8 weeks old and 25-31 g body weight) were obtained from the small animal house of the institute and housed in the polypropylene cages (2-3 animals per cage) with 12-12 h light/dark cycle at 20-25°C ambient temperature. Animals were divided into 4 groups (n=15), i.e. 1. allergic control: fed with synthetic diet (SD), 2. milk-fed group: fed with non-fermented milk containing 2.5% fat (20% water solution) along with SD, 3. DRC-1 Dahi-fed group: fed with DRC-1 control Dahi along with SD, and 4. probiotic Dahi-fed group: fed with probiotic Dahi along with SD for 21 days. SD contained 38.5% starch, 20% casein, 25% sucrose, 10% refined oil, 1% vitamin mixture, 5% mineral mixture, 0.2% choline chloride, and 0.3% methionine. Vitamin and mineral mixtures were prepared and mixed according to Association of Official Agricultural Chemists (12) . Food and water intakes were recorded daily. Allergic response was induced by injecting OVA (20 μg of OVA and 2 mg of Al(OH) 3 at a total volume of 200 l) intraperitoneally on days 0 and 14, and animals (n=5) were sacrificed after 7, 14 and 21 days. The study protocol was approved by the Institutional Animal Ethics Committee, and animals were maintained as per the rules of animal handling and care of the National Institute of Nutrition, Hyderabad, India.
Preparation of Serum Samples
Blood was drawn from orbital venous plexus in a vial at 7, 14 and 21 days of experimental periods, and serum was separated by centrifuging blood samples at 5000 x g for 10 min and then frozen at -80°C till further use.
Isolation and Culture of Splenocytes
Mice were sacrificed by cervical dislocation with brief anesthesia. The spleen was removed aseptically and suspended in RPMI 1640 culture medium supplemented with 10% fetal calf serum (FCSheat inactivated at 56°C for 30 min), sodium bicarbonate, sodium pyruvate, HEPES, penicillin, and streptomycin. Splenocytes were prepared by gently teasing splenic tissues using sterile needle and forceps. Suspension was allowed to stand for 2 min to sediment tissue clumps. The splenocytes-enriched upper portion of the medium was transferred to a 15 ml sterile centrifuge tube and centrifuged at 1000 x g for 5 min. Cells were washed with RPMI medium and red blood cells (RBCs) lysed by 1 ml of erythrocyte lysis buffer (10 ml Tris HCl 0.17M and 90 ml of NH4Cl 0.6M, pH-7.2). Erythrocyte lysis buffer was washed out by adding 5 ml of culture medium and centrifuging at 1000 x g for 5 min. After washing twice, splenocytes were suspended in 1 ml of RPMI 1640 containing 10% FCS and cells were counted from a small aliquot of cell suspension. Finally, cells were plated on a 96-well plate containing 1 μg/well OVA in 100 μg of RPMI with 10% FCS (n=4 per animal sample) and allowed to grow for 48 h at 37°C in CO 2 incubator. After incubation, supernatant media was harvested from half of the samples (n=2 from each animal sample) and used for determination of IgE and cytokines, and the remaining wells were used for determination of lymphocyte proliferation index.
Measurement of Total IgE
Total IgE in serum and supernatant of cultured splenocytes was determined by using ELISA kit (Bethyl Laboratories, Montgomery, TX, USA). Operating procedures strictly followed the manufacturer's instructions. The principle of the ELISA kit was to employ the quantitative sandwich enzyme immunoassay.
Measurement of OVA-Specific IgE
OVA-specific IgE in serum and supernatant of cultured splenocytes was determined by using indirect ELISA (13) . In brief, 100 μl of antigen (OVA; 100 μg/ml) in 0.06 M carbonate buffer was coated in test wells and 100 μg of carbonate buffer alone in control wells by incubating overnight at 37°C. After drying, 200 μl of 70% methanol was added in each well and left for 20 min to fix antigen and dried by incubating at 37°C for 10 min (14) . Free binding sites were blocked by adding 350 μl of blocking solution and incubated at room temperature for 1 h with occasional shaking. Blocking solution was removed and wells were washed three times with PBS/T. Serum (100 μl) was added to each well and the plate was incubated for 1 h at 37°C with occasional shaking. After washing, goat antimouse IgE-HRP conjugate secondary antibody was added. After washing, TMB substrate solution was added for color development and the reaction stopped with 100 μl of 4N H 2 SO 4 . Optical density (OD) was measured at 450 nm using ELISA plate recorder (Model ETY-119, Oriental Instruments Ltd, Tokyo, Japan), and OVA-specific IgE concentration was expressed as OD/100 μl.
Estimation of Cytokine Levels
Cytokines in serum and supernatant of culture medium were measured by ELISA kits (IFN-γ, interleukin (IL)-4 and IL-6 [Bender Medsystem, Delhi, India] and IL-2 [Genetix Asia Pvt. Ltd., Delhi, India]). Assays were performed following the instructions of the manufacturers.
Cell Proliferation Assay
Proliferative response of splenocytes was estimated using the colorimetric MTT assay (15) . Briefly, 10 μl fresh filtered MTT [3-(4,5-dimethlythiazol2yl)-2,5-diphenyl tetrazolium bromide; 5 mg/ml dissolved in RPMI-1640] was added in 48 h cultured lymphocytes and the plate was incubated for 4 h at 37°C. During this period, formazan crystals were formed at the bottom of each well. Spent media along with suspension of cultured cells was pipetted out, and 100 μl of acid isopropanol (0.1 N HCl in anhydrous isopropanol) was mixed to dissolve crystals. After a few minutes at room temperature, OD was measured by using a plate analyzer in dual wavelength (i.e. test wavelength of 540 nm and reference wavelength of 630 nm). Plates were normally read within 1 h of adding acid isopropanol. Cell proliferation was expressed as proliferation index (A540 with OVA/A540 without OVA).
Statistical Analysis
Results were expressed as mean ± standard error of mean. Statistical significance was tested by employing analysis of variance (ANOVA) and comparison between means was calculated by either Duncan's multiple range test (DMRT). Differences of p<0.05 were considered statistically significant.
RESULTS
Effect on Total IgE Production
Total serum IgE levels in normal mice at basal level were 150.12 ng/ml, which increased significantly and reached 535 ng/ml after 21 days of OVA-immunization in the control group of mice ( Figure 1) . Interestingly, elevation of IgE levels in serum were almost completely suppressed in animals fed with probiotic Dahi and levels were maintained similar to basal during the entire experimental period. While a moderate suppressive effect on increased IgE levels was also observed in DRC-1 (control) Dahi-fed animals, it was abstractedly mild compared to probiotic Dahi ( Figure 1A) . No significant suppressive effect was observed on serum IgE levels in milk-fed animals during the entire experimental period.
Furthermore, the suppressive effect of probiotic Dahi on total IgE in OVA-stimulated cultured splenocytes collected from different experimental groups was also confirmed ( Figure 1B) , and results showed that the production of total IgE was also fully suppressed by splenocytes collected from probiotic Dahi-fed animals during the entire experimental period (21 days). Figure 2 clearly shows that OVA-specific IgE was significantly increased in serum as well as supernatant of OVA-challenged splenocytes, indicating that the increased total IgE was due to increased OVA-specific IgE during the entire experimental period. Further, the feeding of probiotic Dahi significantly suppressed the elevation of OVA-specific IgE in serum as well as supernatant of OVAstimulated splenocytes, while feeding of control Dahi and milk were unable to restrict elevation of these antibodies in both serum as well as supernatant of cultured splenocytes.
Effect on OVA-Specific IgE Production
Effects on Cytokine Production
The circulatory levels of cytokines, i.e. IFN-γ, IL-2, IL-4 and IL-6 were unchanged in the serum of mice in all groups, except for a slight increase in IFN-γ and slight decrease in IL-4 levels in the probiotic Dahi-fed animals (data not shown). However, when we examined the production of these cytokines in the supernatant of OVA-stimulated cultured splenocytes collected from all experimental groups, it was seen that the levels of IFN-γ and IL-2 were significantly decreased and levels of IL-4 and IL-6 were significantly increased in the supernatant of OVA-stimulated cultured splenocytes collected from control mice. Feeding of probiotic Dahi reversed this effect by significantly increasing production of IFN-γ and IL-2 and decreasing production of IL-4 and IL-6 in the supernatant of splenocytes collected after the first OVA-injection (after 7 days) and also remained similar after the second OVA-injection on day 14 (Tables 1 and 2 ). However, levels of IFN-γ and IL-2 also increased slightly in the supernatant of cultured splenocytes collected from mice fed with DRC-1 (control) Dahi and milk, but values were distantly lower than with probiotic Dahi. Figure 3 show that splenocyte proliferation in terms of proliferation index was continuously increased after challenging with OVA in mice (control group) up to day 21 of the experimental period. While feeding of probiotic Dahi completely suppressed the OVA-induced proliferation rate of splenocytes, feeding of control Dahi also exhibited inhibitory effects on proliferation of splenocytes, but it was vaguely effective compared to probiotic Dahi. No effect on suppression of OVA-stimulated splenocyte proliferation was observed in milk-fed animals.
Effect on Cell Proliferation of Cultured Splenocytes
Data in
DISCUSSION
In the present study, we observed that feeding of probiotic Dahi is remarkably effective in suppressing OVA-induced allergic consequences in mice. This effect of probiotic Dahi was distantly dominant compared to control Dahi and milk feeding. As the allergy is a health threat with increasing prevalence, it demands the development of prevention strategies (16) . Consumption of functional foods might be one such strategy that can prevent the rapidly increasing prevalence of allergy. OVAinduced allergy in mice is a good model for studying various food allergic consequences and validating new treatment strategies (17) . OVA is an allergen that induces allergy when injected (i.v./ i.p./i.n.) into the body of experimental animals. During induction of OVA-mediated allergy, various common characteristics of human food allergy such as diarrhea and anxiety have been observed in mice models (18) . In the present study, we did not observe diarrhea or vomiting among any of the mice groups, which indicates that the selected dose of OVA was not chronic, which can disrupt the normal immunomodulatory function in mice.
Moreover, OVA-induced allergy is a common model to study in-vitro and in-vivo IgE-mediated immunological consequences. Various strains of LAB have been reported to reduce OVA-induced allergic consequences in cell culture and animal models (4) (5) (6) 19) . In the present study, feeding of pro- biotic Dahi significantly suppressed the elevation of serum levels of total and OVA-specific IgE in OVA-injected mice. Similarly, splenocytes collected from mice fed with probiotic Dahi completely lost the capacity of OVA-stimulated production of total and OVA-specific IgE. This indicates that probiotic Dahi inhibited the OVA-mediated allergic response in the immune cells to produce IgE antibodies. Similar results were also found in several previous studies demonstrating that ingestion of LAB decreased total and OVA-specific IgE levels in cell culture and mice models (13, (20) (21) (22) . However, in these studies, pure LAB cultures and/or their extracts were used, while in the present study, we prepared a fermented milk product (Dahi) that may be used for direct human consumption as a safe, easily consumed and palatable functional food with anti-allergic effects.
Moreover, IgE-induced allergy is reported to be caused by a skew in the balance between Th1 and Th2 immune cell response (23, 24) . One of the main mechanisms behind the regulation of IgE production by the probiotic Dahi might be preservation of balance between Th1 and Th2 response. The results of the present study proved that feeding of probiotic Dahi suppressed the production of Th2-specific cytokines (IL-4 and IL-6) and increased production of Th1-specific cytokines (IL-2 and IFN-γ). It indicates that probiotic Dahi may skew the OVA-induced Th2 immune response towards Th1 immune response, and hence might be beneficial in preventing IgE-mediated allergy. The regulation of allergic response depends on the proliferation and regulation of immune cells such as B, T and natural killer -cells (23, 24) . In the present study, we observed that probiotic Dahi feeding significantly suppressed the OVAstimulated splenocyte proliferation. These findings indicate that probiotic Dahi has the potential to induce immune cells in a beneficial manner for regulating the proliferation as well as functional activity in response to an allergen.
While the exact mechanism of action of probiotic Dahi is not known, our previous results showed that probiotic Dahi consumption strengthens the innate immune response in mice. Moreover, it can be clearly seen from the results of present study that anti-allergic effects of probiotic Dahi were remarkably higher than of control Dahi and milk, which indicates that the anti-allergic potential of probiotic Dahi increased due to addition of probiotic bacteria. (27, 28) , which are well known for their immunomodulatory functions (29) (30) (31) (32) . This further proves the higher biological efficacy of probiotic Dahi than milk and control Dahi, especially with regard to suppression of OVA-induced allergic consequences. Although probiotic Dahi was found dominantly effective in suppressing OVA-induced allergic consequences, further investigations are required to know the detailed mechanism of action of probiotic Dahi and/or its bio-constituents.
In conclusion, probiotic Dahi can be put forward as a new alternative therapeutic agent for prevention of allergic diseases to benefit the millions of people suffering from food allergy. Despite these observations, however, much research is still needed to determine the true efficacy and safer use of probiotic Dahi for human consumption in preventing food allergy.
